methadone has been researched along with efavirenz in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baumann, P; Decosterd, LA; Eap, CB; Marzolini, C; Telenti, A; Troillet, N | 1 |
| Blayac, JP; Faucherre, V; Peyriere, H; Pinzani, V | 1 |
| Eap, CB | 1 |
| Back, DJ; Barry, MG; Clarke, SM; Gibbons, SE; Mulcahy, FM; Reynolds, HE; Tjia, J | 1 |
| Fornataro, K | 1 |
| Clarke, SM; Mulcahy, FM | 1 |
| Calvo, R; Carlos, MA; Lukas, JC; Rodriguez, M; Suarez, E | 1 |
| Back, DJ; Boffito, M; Di Perri, G; Hoggard, PG; Reynolds, HE; Rossati, A | 1 |
| Barril, J; Esteban, J; Garcia-Pérez, AG; Giménez, J; Gimeno, C; Mora, E; Pellín, Mde L | 1 |
| Besson, J; Cavassini, M; Eap, CB; Favrat, B; Monnat, M; Pelet, A | 1 |
| Bedynek, PS; Campbell, S; Crafford, A; Ensign, D; Hoffer, C; Kharasch, ED; Kim, T; London, A; Stubbert, K; Whittington, D | 1 |
| Dong, X; Hong, L; Huang, S; Lei, S; Li, H; Li, X; Xie, R; Xin, J; Yang, C; Yang, X; Zhang, B; Zhang, R | 1 |
2 review(s) available for methadone and efavirenz
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Efavirenz therapy in drug users.
Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Methadone; Oxazines; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Substance-Related Disorders | 2000 |
3 trial(s) available for methadone and efavirenz
| Article | Year |
|---|---|
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.
Topics: Adult; Alkynes; Analgesics, Opioid; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Oxazines; Reverse Transcriptase Inhibitors; Substance Withdrawal Syndrome | 2001 |
Increase of R-/S-methadone enantiomer concentration ratio in serum of patients treated with either nevirapine or efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Induction; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Methadone; Narcotics; Nevirapine; Oxidoreductases, N-Demethylating; Stereoisomerism | 2008 |
Outcomes of Methadone Maintenance Therapy Combined with Rilpivirine/Efavirenz in Treatment-Naive HIV-Infected Patients.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Humans; Methadone; Prospective Studies; Rilpivirine; Viral Load | 2021 |
9 other study(ies) available for methadone and efavirenz
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efavirenz decreases methadone blood concentrations.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Lamivudine; Methadone; Oxazines; Reverse Transcriptase Inhibitors; Stavudine; Substance Withdrawal Syndrome | 2000 |
Methadone withdrawal symptoms with nevirapine and efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Male; Methadone; Narcotics; Nevirapine; Oxazines; Substance Withdrawal Syndrome | 2000 |
Comment: opiate withdrawal symptoms induced by antiretroviral drugs.
Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Humans; Methadone; Nevirapine; Opioid-Related Disorders; Oxazines; Substance Withdrawal Syndrome | 2000 |
Methadone and anti-HIV drugs.
Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Methadone; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; Substance-Related Disorders | 1999 |
Pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase efavirenz.
Topics: Alkynes; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Methadone; Narcotics; Oxazines; Reverse Transcriptase Inhibitors | 2002 |
Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Interactions; HIV Infections; Humans; Kinetics; Methadone; Narcotics; Oxazines; Prospective Studies; Substance Withdrawal Syndrome; Time Factors | 2002 |
Usefulness of methadone plasma concentration measurement in patients receiving nevirapine or efavirenz.
Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Drug Interactions; Humans; Methadone; Nevirapine; Reverse Transcriptase Inhibitors; Substance Withdrawal Syndrome | 2011 |
Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics.
Topics: Adolescent; Adult; Alkynes; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cross-Over Studies; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Interactions; Female; Hepatocytes; Humans; Male; Methadone; Oxidoreductases, N-Demethylating; Young Adult | 2012 |